Eosinophilic Fasciitis vs Scleroderma: Key Differences

If your skin biopsy returned a diagnosis of eosinophilic fasciitis (EF) instead of systemic scleroderma, your doctor has found that your condition is an entirely different disease with a generally favorable outlook. While both conditions cause severe skin thickening, eosinophilic fasciitis does not cause Raynaud’s phenomenon or damage to the nailfold capillaries, and it usually spares the fingers and face ^[1][2][3]. EF often features the “groove sign” (where veins look like sunken trenches on the arms or legs) ^[4][5][6]. Crucially, an EF diagnosis completely changes your treatment plan, as EF typically responds very well to corticosteroid medications, which are generally avoided in systemic scleroderma ^[7][8][9].

Why They Are Initially Confused

Eosinophilic fasciitis and systemic scleroderma are both rare conditions that cause your skin to become thick, hard, and bound down ^[10][2][3]. This severe skin thickening can restrict your movement and cause joint contractures (stiffness that prevents joints from fully straightening). Because of these visible similarities, EF is considered a major “mimic” of systemic scleroderma, and doctors often suspect systemic scleroderma first.

However, a deep skin biopsy reveals what is happening under the surface. Systemic scleroderma involves scarring in the upper layers of the skin (the dermis), while EF causes severe inflammation in the fascia—the deep layer of connective tissue that surrounds your muscles ^[10][3][11]. To accurately diagnose EF, doctors must perform a full-thickness biopsy that removes tissue all the way down to the muscle layer ^[12][13][14]. This is typically an outpatient procedure done under local anesthesia.

Key Differences in Symptoms

Your doctor rules out systemic scleroderma and confirms EF based on several specific clinical differences:

• Raynaud’s Phenomenon: Almost all patients with systemic scleroderma experience Raynaud’s phenomenon (fingers turning white, blue, and red in the cold). This is typically absent in EF ^[1][2][3].
• Capillary Changes: Systemic scleroderma damages the tiny blood vessels at the base of the fingernails. When your doctor looks at your cuticles under magnification, nailfold capillary abnormalities are absent in EF ^[2][3].
• Location of Skin Thickening: Systemic scleroderma usually starts by affecting the fingers (a condition called sclerodactyly) and the face. EF typically spares the fingers and face, instead affecting the forearms, upper arms, lower legs, thighs, and trunk ^[1][2][3].
• The “Groove Sign”: This is a classic hallmark of EF. Because the deep fascia becomes swollen and thick while the superficial veins remain normal, the veins appear to sink inward ^[3][5]. When you elevate your affected arm or leg, you may see visible depressions or “grooves” running along the path of the veins ^[4][5][6].
• Internal Organ Involvement: Systemic scleroderma frequently causes scarring in internal organs, such as the lungs, esophagus, heart, and kidneys ^[2][3]. EF is primarily limited to the deep skin tissues and does not typically involve these internal organs, which gives EF a much more favorable long-term prognosis ^[2][3].
• Blood Work: EF gets its name from eosinophils, a type of white blood cell. Many patients with EF initially have highly elevated levels of eosinophils in their bloodstream, which is not a defining feature of systemic scleroderma ^[15][10][8]. However, it is important to note that these levels can fluctuate and may be completely normal later in the disease or after starting treatment, so a normal eosinophil count does not rule out EF ^[15][8].

How the Diagnosis Changes Your Treatment

Getting the correct diagnosis of eosinophilic fasciitis is critical because the treatment path is entirely different from systemic scleroderma.

For EF, the first-line treatment is high-dose systemic corticosteroids (such as prednisone) ^[8][6][9]. Patients with EF usually have a dramatic and rapid improvement when treated with these steroids, often noticing reduced stiffness and skin softening quickly ^[8][6][9]. However, because high-dose steroids can cause side effects like weight gain, sleep disturbances, or mood changes, your doctor will monitor you closely and aim to slowly taper the dose as your symptoms improve.

In stark contrast, high-dose corticosteroids are usually avoided in systemic scleroderma. They are less effective for scleroderma skin thickening and can trigger a dangerous complication called scleroderma renal crisis, which severely damages the kidneys ^[7].

If your EF does not respond completely to corticosteroids alone, or if your doctor wants to reduce your steroid dose to minimize side effects, they may add a second-line immunosuppressive medication, such as methotrexate ^[12][16][17].